“GMP-certified” describes factory processes, not what is in the bottle. The claim does not name a certifier or public register that a shopper can check.

Strivlabs Peak Potential
Checked against public sources on July 25, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
The observed listing says it is tested, but names no lab or certifier. A testing badge without an issuer or report is a marketing claim, not evidence. Ask for the lab name and lot-specific report.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
The checks, one by one
The public sources did not settle the marketing promises on this label.
◐Partly confirmed2
Published research exists for ingredients in this formula — see Related research below. Whether this product’s doses match those studies could not be confirmed.
Ingredient research can support context, but it is not a trial of this exact product.
?Couldn’t verify independently2
“Made in USA” can describe only final bottling. Ingredient-sourcing records were not located for this product.
No named laboratory or lot-specific certificate was found for this exact product. The exact brand page names no testing issuer and links no product-bound report. NSF, IFOS, USP, and Informed-Sport were not checked in this record. This is a public-evidence limit, not a finding that testing did not occur.
We looked and found no public proof. That does not count against the product.
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
Category context: sexual-enhancement products carry documented FDA risk
This is category history, not proof about this product, but it changes how much unsupported claims deserve to be trusted.
Evidence and sources
FDA's health-fraud program documents sexual-enhancement products as the most common supplement category found to contain undeclared prescription-drug ingredients. This is a category-level documented fact from FDA's public database — not a test result for this specific product. So…
Locked evidence record →Open the full source-linked findingEvery ingredient shows its amount · 12 ingredients listed.
Every ingredient shows its real amount — nothing is hidden in a proprietary blend.
Evidence and sources
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Locked evidence record →Open the full source-linked findingThe barcode identity checks out · 198715685336.
The barcode matches, so we are checking the right product rather than a look-alike.
Evidence and sources
The brand's store lists this exact barcode as “Peak Potential” (variant: Default Title) — identity confirmed across retailer listings.
Locked evidence record →Open the full source-linked findingWhat remains open 3
- No matched to this exact product public label filing is saved in this record.
- Barcode checksum is valid; no independent product record was found.
- No dated review-history series is on file yet.
These are evidence gaps, not strikes against the product.
Filed address
30 N Gould St, Ste R, Sheridan, Wyoming 82801, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
Dose and research context
The label amount is shown beside the ranges used in the linked ingredient studies.
What the research says about these amounts
Not a score. Studies disagree with each other and change over time, so this sits beside the evidence rather than counting toward it — it is here so you can read the sources yourself.
The panel lists 400 mg of ashwagandha per serving. Studies we found used 250 mg–600 mg a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
The panel lists 5 mg of boron per serving. Studies we found used 3 mg–10 mg a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
The panel lists 100 mg of tongkat ali (Eurycoma longifolia) per serving. Studies we found used 200 mg–400 mg a day, so this sits below that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
The panel lists 300 mg of fenugreek per serving. Studies we found used 500 mg–600 mg a day, so this sits below that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
Price check for this exact product
Amazon
Exact UPC/GTIN match$1.40 per labeled serving
matching UPC/GTIN · checked Jul 25, 2026
View on Amazon ↗Brand website
Exact UPC/GTIN match$2.00 per labeled serving
matching UPC/GTIN · checked Jul 25, 2026
View on Brand website ↗iHerb
Not confirmedSearch results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.
Search iHerb ↗Target
Not confirmedSearch results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.
Search Target ↗Walmart
Not confirmedSearch results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.
Search Walmart ↗Same UPC/GTIN observed across 2 sellers. Amazon was lowest at $41.98; Brand website was highest at $60.00 — a $18.02 range at check time.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
Want to inspect the evidence?
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built July 25, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.